Clinical Trial Update: Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement [Phase 3]

View source ↗

Summary

A Phase 3 trial update on using colchicine in patients undergoing transcatheter aortic valve replacement (TAVR) to address atrial fibrillation onset post-proced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Transcatheter Aortic Valve Replacement

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Transcatheter Aortic Valve Replacement, Atrial Fibrillation New Onset | Phase 3 | Status: COMPLETED